Author/Authors :
Wright، نويسنده , , Alex and Hecker، نويسنده , , John and McDonald، نويسنده , , Gail، نويسنده ,
Abstract :
Objective:
ermine if a dextrose-saline solution manufactured under commercial conditions and containing 1 IU per ml of heparin prolongs the use of infusion sites in children.
:
-blind randomized trial.
ts:
children in a medical ward.
e Measures:
e of infusion sites from phlebitis and/or extravasation.
ention:
on of use of infusion sites was calculated to the nearest hour.
tics:
iate survival analysis.
s:
dian time to failure when solutions contained the heparin (97 hours) was significantly increased (p<0.0001) compared with control solutions (43 hours).
sions:
solutions containing low-dose heparin is recommended for children who might have problems with venous access.